Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 65.10% vs -43.77% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 28.70% vs 116.00% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 70.00% vs 42.86% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 54.66% vs 8.98% in Mar 2024
Compare Balance Sheet Results of Saroja Pharma In
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.02
1.50
2.52
168.00%
Share Warrants & Outstandings
Total Reserve
11.66
11.64
0.02
0.17%
Shareholder's Funds
15.68
13.14
2.54
19.33%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.38
0.00
1.38
0.00%
Secured Loans
0.40
0.00
0.40
0.00%
Unsecured Loans
0.98
0.00
0.98
0.00%
Deferred Tax Assets / Liabilities
0.01
-0.01
0.02
200.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
1.39
-0.01
1.40
14,000.00%
Current Liabilities
Trade Payables
13.65
0.00
13.65
0.00%
Other Current Liabilities
0.77
0.01
0.76
7,600.00%
Short Term Borrowings
8.08
0.00
8.08
0.00%
Short Term Provisions
0.00
0.20
-0.20
-100.00%
Total Current Liabilities
22.49
0.21
22.28
10,609.52%
Total Liabilities
39.55
13.34
26.21
196.48%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2.85
0.11
2.74
2,490.91%
Less: Accumulated Depreciation
0.34
0.10
0.24
240.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.51
0.01
2.50
25,000.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
8.61
0.00
8.61
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.34
0.01
0.33
3,300.00%
Long Term Loans & Advances
0.88
2.51
-1.63
-64.94%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
12.34
2.53
9.81
387.75%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.10
0.00
0.10
0.00%
Sundry Debtors
26.58
0.00
26.58
0.00%
Cash and Bank
0.33
10.62
-10.29
-96.89%
Other Current Assets
0.16
0.19
-0.03
-15.79%
Short Term Loans and Advances
0.05
0.00
0.05
0.00%
Total Current Assets
27.22
10.81
16.41
151.80%
Net Current Assets (Including Current Investments)
4.73
10.61
-5.88
-55.42%
Total Current Assets Excluding Current Investments
27.22
10.81
16.41
151.80%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
39.55
13.34
26.21
196.48%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
9.46
0.00
9.46
0.00%
Book Value per share (adjusted)
38.99
87.63
-48.64
-55.51%
Annual - Borrowings
Borrowings 9.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 65.10% vs -43.77% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 11.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 28.70% vs 116.00% in Mar 2024
Annual - Investments
Investments 0.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 70.00% vs 42.86% in Mar 2024
Annual - Current Assets
Current Assets 27.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 54.66% vs 8.98% in Mar 2024






